Abstract:The present study investigates the underlying mechanisms of treatment with osthole (OST) combined with lobaplatin in human triple-negative MDA-MB-231 breast cancer cells. Human triple-negative MDA-MB-231 breast cancer cells were treated with different concentrations of OST (0.1, 1, 5, 10, 20, 50, and 100 μM) alone or in combination with 10 μM lobaplatin for 48 h. Cell viability was determined and compared between the treatment groups with the Cell Counting Kit-8 assay. Transcriptome sequencing (Project Number: M-GSGC0250521) was employed to elucidate the gene expression profile of the control group and the OST treatment group, and differentially expressed genes (DEGs) were identified based on the following criteria: log2FC > 0, P < 0.05. KEGG enrichment analysis was employed to determine the biological functions of these DEGs and the related signaling pathways. Finally, flow cytometry and western blotting were used to assess differences in the apoptosis rate and protein expression in MDA-MB-231 cells subjected to different treatments. The findings showed that OST inhibited the growth of MDA-MB-231 cells in a concentration-dependent manner and cell proliferation was significantly inhibited (as indicated by a decrease of 40%) at the OST concentration of 50 μM (P < 0.05). Transcriptome sequencing identified 4712 DEGs, including 2169 upregulated DEGs and 2543 downregulated DEGs. Enrichment analysis indicated that the DEGs played a role in apoptosis, p53 signaling, DNA replication, and cell cycle. In vitro experiments showed that OST and lobaplatin could significantly induce apoptosis in the MDA-MB-231 cells (P < 0.05), as indicated by elevation in the translation level of p53/Bax/caspase-3 p17 and downregulation of the Bcl-2 protein. Finally, combined treatment with OST and lobaplatin had an enhanced anti-tumor effect (P < 0.05) on proliferation and apoptosis, as well as more obvious effects on the related proteins (p53, Bax, Bcl-2, and caspase-3 p17). Thus, OST enhanced the apoptosis-mediated growth inhibitory effect of lobaplatin on breast cancer cells and has potential for the treatment of breast cancer in the future.

Bryostatin 1 Inhibits Reduction In Viability And Induction Of Apoptosis By Hydrogen Peroxide In Saos-2, Osteosarcoma Cells Through Mitochondrial Pathway

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Protection of Oxidative Stress Induced Apoptosis in Osteosarcoma Cells by Dihydromyricetin Through Down-Regulation of Caspase Activation and Up-Regulation of BcL-2

Mechanisms Underlying the Antiapoptotic and Anti-Inflammatory Effects of Monotropein in Hydrogen Peroxide-Treated Osteoblasts.

Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H 2O2-induced oxidative damage-implications for the treatment of osteoporosis

Effects of Panax Notoginseng Saponins on Apoptosis Induced by Hydrogen Peroxide in Cultured Rabbit Bone Marrow Stromal Cells Via Altering the Oxidative Stress Level and Down-Regulating Caspase-3

Polydatin Promotes Apoptosis Through Upregulation the Ratio of Bax/Bcl-2 and Inhibits Proliferation by Attenuating the Β-Catenin Signaling in Human Osteosarcoma Cells.

Proanthocyanidin B2 Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells by Suppressing the PI3K/AKT Pathway

Hydrogen peroxide induces G2 cell cycle arrest and inhibits cell proliferation in osteoblasts.

Effects of the Astragaloside Antagonis H2O2 Induced Mice Osteoblast Poptosis

Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells

Osthole Inhibits Proliferation and Induces Apoptosis in Human Osteosarcoma Cells.

Metabolism Of Reactive Oxygen Species In Osteosarcoma And Potential Treatment Applications

The New Synthetic H2S-Releasing SDSS Protects MC3T3-E1 Osteoblasts against H2O2-Induced Apoptosis by Suppressing Oxidative Stress, Inhibiting MAPKs, and Activating the PI3K/Akt Pathway

Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells.

Effect and Mechanisms of Celastrol on the Apoptosis of HOS Osteosarcoma Cells.

Flavonoid compound breviscapine suppresses human osteosarcoma Saos‐2 progression property and induces apoptosis by regulating mitochondria‐dependent pathway

Effects of butein on human osteosarcoma cell proliferation, apoptosis, and autophagy through oxidative stress

Bryostatin 5 Induces Apoptosis in Acute Monocytic Leukemia Cells by Activating PUMA and Caspases.